HotSpot Therapeutics

company

About

HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.

  • 11 - 50

Details

Last Funding Type
Series C
Last Funding Money Raised
$100M
Industries
Biopharma,Biotechnology,Health Care,Life Science,Therapeutics
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

HotSpot Therapeutics is a biotech startup that focuses on the development of allosteric therapies targeting regulatory sites on proteins. It develops a therapy platform to discover medicines and provide proper treatment to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases, leverages a database of hotspot structures, harnessing the power of data science in its multidisciplinary approach to drug discovery, and helps patients to get treatment against several diseases.

HotSpot Therapeutics was founded in 2017 and is headquartered in Boston, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$100M
HotSpot Therapeutics has raised a total of $100M in funding over 2 rounds. Their latest funding was raised on Nov 29, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 29, 2021 Series C $100M 1 Detail

Investments

Number of Investments
Number of Lead Investments
1
0
HotSpot Therapeutics has made 1 investments. Their most recent investment was on Sep 1, 2018, when Revel raised $4M.
Date Company Name
Round Money Raised Industry Lead Investor
Sep 1, 2018 Revel
Seed $4M Apps

Investors

Number of Lead Investors
Number of Investors
1
HotSpot Therapeutics is funded by 1 investors. Pavilion Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Pavilion Capital Series C